ES2188336A1 - Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen. - Google Patents

Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.

Info

Publication number
ES2188336A1
ES2188336A1 ES200002496A ES200002496A ES2188336A1 ES 2188336 A1 ES2188336 A1 ES 2188336A1 ES 200002496 A ES200002496 A ES 200002496A ES 200002496 A ES200002496 A ES 200002496A ES 2188336 A1 ES2188336 A1 ES 2188336A1
Authority
ES
Spain
Prior art keywords
polyhydroxilated
complexes
trivalent iron
soluble
polyalcoholic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200002496A
Other languages
English (en)
Other versions
ES2188336B1 (es
Inventor
Fernando Fussi
Victor Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tedec Meiji Farma SA
Syntex Uruguaya SA
Original Assignee
Tedec Meiji Farma SA
Syntex Uruguaya SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tedec Meiji Farma SA, Syntex Uruguaya SA filed Critical Tedec Meiji Farma SA
Priority to ES200002496A priority Critical patent/ES2188336B1/es
Priority to KR1020010012607A priority patent/KR20020033020A/ko
Publication of ES2188336A1 publication Critical patent/ES2188336A1/es
Application granted granted Critical
Publication of ES2188336B1 publication Critical patent/ES2188336B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Aductos de albúmina soluble con complejos polihidroxilados (polialcohólicos) de hierro trivalente, método de obtención y preparaciones farmacéuticas y dietéticas. El aducto, soluble en agua, comprende un complejo polihidroxilado de hierro trivalente con albúmina soluble y desensibilizada. El compuesto polihidroxilado comprende un compuesto que contiene más de un grupo hidróxido y que es capaz de formar complejos con hierro trivalente. La albúmina ha sido sometida a un tratamiento térmico, alcalino y oxidante para su solubilización sin afectar a su peso molecular. El aducto se obtiene mezclando la solución del complejo férrico con la solución de albúmina tratada. Estos aductos son adecuados para la administración oral de complejos férricos, por lo que son adecuados para el tratamiento de estados carenciales de hierro y/o para el aporte de dicho elemento.
ES200002496A 2000-10-18 2000-10-18 Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen. Expired - Fee Related ES2188336B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES200002496A ES2188336B1 (es) 2000-10-18 2000-10-18 Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.
KR1020010012607A KR20020033020A (ko) 2000-10-18 2001-03-12 3가철의 폴리히드록실화 착체(폴리알코올)를 가진 가용성알부민의 첨가생성물, 그 취득방법, 그 첨가생성물을포함한 의약조성물 및 식이요법 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200002496A ES2188336B1 (es) 2000-10-18 2000-10-18 Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.

Publications (2)

Publication Number Publication Date
ES2188336A1 true ES2188336A1 (es) 2003-06-16
ES2188336B1 ES2188336B1 (es) 2004-04-01

Family

ID=8495290

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200002496A Expired - Fee Related ES2188336B1 (es) 2000-10-18 2000-10-18 Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.

Country Status (2)

Country Link
KR (1) KR20020033020A (es)
ES (1) ES2188336B1 (es)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655308A1 (en) * 2004-11-03 2006-05-10 Tedec-Meiji Farma, S.A. Adducts of soluble ovalbumin with trivalent iron polyalcohol complexes and method to produce them
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
US11160299B2 (en) 2019-07-11 2021-11-02 Clara Foods Co. Protein compositions and consumable products thereof
US11279748B2 (en) 2014-11-11 2022-03-22 Clara Foods Co. Recombinant animal-free food compositions and methods of making them
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123432A1 (es) * 1996-10-15 1999-01-01 Syntex Sa Aductos de complejos polihidroxilados de hierro trivalente con albumina soluble, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2123432A1 (es) * 1996-10-15 1999-01-01 Syntex Sa Aductos de complejos polihidroxilados de hierro trivalente con albumina soluble, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1655308A1 (en) * 2004-11-03 2006-05-10 Tedec-Meiji Farma, S.A. Adducts of soluble ovalbumin with trivalent iron polyalcohol complexes and method to produce them
ES2258391A1 (es) * 2004-11-03 2006-08-16 Tedec-Meiji Farma, S.A. Aducto de ovoalbumina soluble con complejos polialcoholicos de hierro trivalente y metodo para su obtencion.
US11279748B2 (en) 2014-11-11 2022-03-22 Clara Foods Co. Recombinant animal-free food compositions and methods of making them
US11160299B2 (en) 2019-07-11 2021-11-02 Clara Foods Co. Protein compositions and consumable products thereof
US11800887B2 (en) 2019-07-11 2023-10-31 Clara Foods Co. Protein compositions and consumable products thereof
US11974592B1 (en) 2019-07-11 2024-05-07 Clara Foods Co. Protein compositions and consumable products thereof
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
US11142754B2 (en) 2019-08-07 2021-10-12 Clara Foods Co. Compositions comprising digestive enzymes
US11649445B2 (en) 2019-08-07 2023-05-16 Clara Foods Co. Compositions comprising digestive enzymes

Also Published As

Publication number Publication date
KR20020033020A (ko) 2002-05-04
ES2188336B1 (es) 2004-04-01

Similar Documents

Publication Publication Date Title
WO1999043355A3 (en) Formulations containing oxaliplatin
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
WO2002074238A3 (en) Water soluble and palatable complexes
WO2001066103A3 (en) Treatment of neoplasms by inhalation of carboplatin
CA2263379A1 (en) Method for iron delivery to a patient by transfer from dialysate
ATE283043T1 (de) Medikament zur behandlung intraepithelialer prostataneoplasie
AU2001287850A1 (en) Iron compositions
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
ES2188336A1 (es) Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.
HK1068251A1 (en) Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents
GB8506027D0 (en) Pharmaceutical & dietary compositions
DE69633178D1 (de) Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon
BR9713653B1 (pt) composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.
EP0281070A3 (en) Pharmaceutical composition for the treatment of cancer
ATE140219T1 (de) Chelatbildende mittel
IL141550A0 (en) Methods and compositions for the prevention or treatment of cancer
TR199801732T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
WO1999011256A8 (fr) L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
AU2001279922A1 (en) Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof
GR20000100238A (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων
ES2123432A1 (es) Aductos de complejos polihidroxilados de hierro trivalente con albumina soluble, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.
EP1234585A3 (en) Methods and compositions for the prevention or treatment of cancer
Wasserman et al. Evidence for enhanced toxicity to CPT-11 in patients with Gilbert's syndrome: Two case reports
UA42462A (uk) Бромідний комплекс міді (іі) та кобальту (ііі) з діетаноламіном, що виявляє протипухлинну дію

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030616

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2188336B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20210126